Burn: Clinical Trials

16 trials for Burn, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated, 5 completed, 3 withdrawn, 1 recruiting. 16 Phase 2, 11 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 216Terminated 6, Completed 5, Withdrawn 3, Recruiting 1, Unknown 1
Phase 311Terminated 6, Withdrawn 3, Completed 2

Follow Burn: new trials by email Literature Review of Burn trials Research Report on Burn

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns
KJ101, Chymotrypsin, Placebo (Sodium Chloride Injection 0.9%) - Burn, Burn Wounds - Partial Thickness (2nd Degree)
Phase 2RecruitingShanghai Bao Pharmaceuticals Co., Ltd.1442025-06-162025-06-17
Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Burn
Autologous epidermal cell suspension, Silver sulfadiazine ointment - Burn
Phase 2CompletedSCARM Institute, Tabriz, Iran402019-04-102020-03-18
Fenofibrate and Propranolol in Burn Patients
Fenofibrate, Placebo, Propranolol - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston182015-11-012019-11-29
Propranolol in Severely Burned Children
Propranolol, Placebo - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston632013-12-012019-09-24
Protective Effects of Propranolol in Adults
Propranolol, Placebo - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston472013-07-012019-11-29
Vitamin E Supplementation in Burned Patients
Vitamin E - Burn
Phase 2 / Phase 3CompletedThe University of Texas Medical Branch, Galveston272013-02-012026-07-20
Low Dose Ketamine VR Analgesia During Burn Care Procedure
Virtual Reality - Burn
Phase 2CompletedNational Institute of General Medical Sciences (NIGMS)32012-07-012017-09-01
Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns
DGD - Burn
Phase 2CompletedMediWound Ltd362009-12-202021-09-09
Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate
fenofibrate, placebo - Burn
Phase 2 / Phase 3WithdrawnThe University of Texas Medical Branch, Galveston2008-08-012012-12-11
Use of Banana Leaf Dressing on Donor Site Wounds
Banana Leaf Dressing, Hydrocolloid Dressing (DuoDERM CGF) - Burn
Phase 2UnknownUniversity of the Philippines102006-10-012020-04-24
New Treatment for Donor Sites
Application of donor site dressing [scarlet red, Microbial Nanocellulose (NC), or hyaluronan and thrombin (HT)], Blood sample, Biopsy - Burn
Phase 2 / Phase 3WithdrawnThe University of Texas Medical Branch, Galveston2006-01-012012-12-11
Evaluation Perioperative Nutrition on Donor Site Healing in Patients Undergoing Reconstructive Burn Surg
Juven (Ross Products) protein supplement - Burn, Reconstructive Surgical Procedure
Phase 2 / Phase 3TerminatedShriners Hospitals for Children382005-06-012012-06-19
Use of Amnion on Partial Thickness Burns
Amnion, Polysporin/Bacitracin/Mycostatin - Burn
Phase 2 / Phase 3WithdrawnThe University of Texas Medical Branch, Galveston2005-06-012012-11-15
Virtual Reality Pain Control During Burn Wound Care
Virtual Reality Distraction - Burn
Phase 2 / Phase 3CompletedNational Institute of General Medical Sciences (NIGMS)1842002-02-012013-04-19
Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks
Sulfamylon 5% and Silver Nitrate Soaks - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston981995-07-012023-06-22
Bone Disease in Severely Burned Children
Tetracycline, Duel Energy X-Ray Absorptiometry (DEXA), Bone Biopsy - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston2541992-10-012014-06-06

Narrower conditions

Burns (16)  ·  Wounds and Injuries (2)  ·  Cicatrix (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Wound Infection (1)

Broader conditions

Wounds and Injuries (14)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Fibrosis (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Infections (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Metoprolol (3)  ·  Propranolol (3)  ·  Fenofibrate (2)  ·  Bandages, Hydrocolloid (1)  ·  Biopsy (1)  ·  Blood Specimen Collection (1)  ·  Chymotrypsin (1)  ·  Hyaluronic Acid (1)  ·  Mafenide (1)  ·  Scarlet Red (1)  ·  Silver Nitrate (1)  ·  Tetracycline (1)  ·  Thrombin (1)  ·  Vitamin E (1)  ·  alpha-Tocopherol (1)

Sponsors

The University of Texas Medical Branch, Galveston (9)  ·  National Institute of General Medical Sciences (NIGMS) (2)  ·  MediWound Ltd (1)  ·  SCARM Institute, Tabriz, Iran (1)  ·  Shanghai Bao Pharmaceuticals Co., Ltd. (1)  ·  Shriners Hospitals for Children (1)  ·  University of the Philippines (1)

Countries

United States (9)  ·  Canada (1)  ·  China (1)  ·  India (1)  ·  Iran (1)  ·  Israel (1)  ·  Philippines (1)

Top investigators

David N Herndon, MD (6)  ·  David Herndon, MD (1)  ·  David R Patterson, Ph.D. (1)  ·  David R. Patterson, Ph.D. (1)  ·  Jeane Azarcon, MD (1)  ·  Klein Gordon, M.D. (1)  ·  Linda E Sousse, PhD, MBA (1)  ·  Lior Rosenberg, MD (1)  ·  Mohamad Reza Ranjkesh, MD, Dermatologist (1)  ·  Perenlei Enkhbaatar, MD, PhD (1)  ·  Theresa M Mayes, RD,LD (1)

Results publications

PMID 17245174, PMID 24616577, PMID 25426401, PMID 26419871, PMID 26706649

NIH funding

R01GM042725 (1)